Vybrique is an oral film formulation of sildenafil, a phosphodiesterate-5 inhibitor, designed to dissolve on the tongue without the need for food or water.

FDA has approved Vybrique, the first oral film formulation of sildenafil for the treatment of erectile dysfunction, offering ...

In today’s Pharmaceutical Executive Daily, FDA approves Vybrique for erectile dysfunction, experts argue Phase III clinical ...

A honey energy product is being recalled for containing an undeclared ingredient used for erectile dysfunction treatment.

IBSA USA, the U.S. subsidiary of the Swiss pharmaceutical company IBSA, announced today that the Food and Drug Administration ...

ED is characterized by the inability to achieve or maintain an erection sufficient for sexual activity. It can be caused by various factors, including physical conditions such as cardiovascular ...

From excessive exercise to poor heart health and obstructive sleep apnoea, a number of factors can drive erection issues ...

There are four main causes of ED: psychogenic, vascular, hormonal and neurologic.

The FDA issued a recall Wednesday for a honey energy supplement after an undeclared erectile dysfunction medication was found ...

A new treatment for erectile dysfunction just passed its first phase of human testing in Brazil. The treatment comes from the venom of the Brazilian banana spider. The treatment is a gel, not a pill, ...